We initially utilized a published PAM50-gene shrunken centroid classifier [17] on our MAS5 normalized GeneChip data as a benchmark for a method that has been used to partition ER+/PR+ and HER2- negative breast tumor samples into luminal-A and luminal-B subtypes. This evidence concerns the gene ESR1 and breast neoplasm.